Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $53.13 | $17.80 | 198.46% | 221.38x | 19.65x | 16.23x | 43.51x | 1.12x | $41.15M | 0.88% | $108.58M | 1.23 | $4.68B | 87.43 | ||
| SLNO | SOLENO THERAPEUTICS INC | $52.94 | $61.44 | -13.83% | 28.62x | 13.15x | 9.68x | 5.57x | 0.36x | $105.42M | 3.82% | $495.80M | 9.52 | $2.68B | 24.92 | ||
| CORT | CORCEPT THERAPEUTICS INC | $51.20 | $16.38 | 212.49% | 111.30x | 94.36x | 6.95x | 8.62x | 1.28x | $119.79M | 2.24% | $637.99M | 6.11 | $5.40B | -786.09 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $284.84 | $99.76 | 185.53% | 65.33x | 40.17x | 8.83x | 35.36x | 1.30x | $641.34M | 1.69% | $1.08B | 8.09 | $39.29B | 42.50 | ||
| ADMA | ADMA BIOLOGICS INC | $7.88 | $11.90 | -33.78% | 11.42x | 7.94x | 3.65x | 4.68x | 0.33x | $107.90M | 5.80% | $390.33M | 1.65 | $1.89B | 8.51 | ||
| ASND | ASCENDIS PHARMA A | $238.67 | $105.00 | 127.32% | 25.30x | 55.95x | 14.55x | 25.82x | 1.54x | $52.94M | 0.36% | $574.09M | 9.24 | $15.21B | 163.05 | ||
| KRYS | KRYSTAL BIOTECH INC | $312.88 | $103.75 | 201.56% | 40.37x | 39.80x | 21.96x | 7.22x | 1.76x | $237.38M | 2.59% | $1.28B | 43.59 | $8.73B | 40.81 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.80 | $16.56 | -34.79% | 5.27x | 21.78x | 5.16x | 3.10x | 0.69x | $56.42M | 8.94% | $205.80M | 3.52 | $543.99M | 3.76 | ||
| VCEL | VERICEL CORP | $32.92 | $8.88 | 270.88% | 76.56x | 74.19x | 5.72x | 4.72x | 1.74x | $47.49M | 2.84% | $356.23M | 7.02 | $1.67B | 41.23 | ||
| HALO | HALOZYME THERAPEUTICS INC | $66.41 | $72.55 | -8.47% | 22.44x | 8.05x | 5.20x | 35.86x | 0.41x | $667.65M | 8.51% | $219.64M | 1.86 | $9.71B | 15.56 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $58.37 | $16.39 | 256.18% | 59.56x | 52.91x | 5.92x | 7.41x | 1.83x | $164.23M | 3.68% | $605.69M | 7.92 | $4.31B | 38.66 | ||
| RPRX | ROYALTY PHARMA PLC | $51.65 | $42.71 | 20.92% | 27.04x | 9.76x | 9.24x | 2.99x | 0.55x | $2.34B | 10.38% | $9.94B | 22.75 | $38.11B | 32.76 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.98 | $3.07 | 29.84% | 16.58x | 14.58x | 2.44x | 3.85x | 0.78x | $4.11M | 1.28% | $82.33M | 1.03 | $253.01M | 11.91 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.14 | $2.90 | 111.95% | 87.71x | 51.38x | 3.33x | 81.47x | 0.85x | $47.52M | 4.54% | $13.01M | 0.08 | $1.21B | 22.59 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $223.61 | $49.82 | 348.86% | 475.77x | 9.18x | 3.12x | 3.10x | 1.64x | $1.30B | 9.38% | $4.53B | 73.22 | $17.59B | 26.05 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $52.58 | $42.26 | 24.41% | 37.56x | 11.64x | 3.12x | 1.64x | 0.53x | $767.06M | 7.58% | $6.21B | 32.27 | $8.52B | 17.66 | ||
| TECH | BIO-TECHNE CORP | $47.42 | $16.82 | 181.85% | 66.79x | 23.45x | 6.12x | 3.56x | 1.27x | $269.60M | 3.64% | $2.09B | 13.34 | $7.50B | 29.32 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.55 | $4.94 | -48.42% | 17.00x | 3.73x | 2.14x | 2.50x | 0.21x | -$12.62M | -8.82% | $59.02M | 1.05 | $110.25M | 12.48 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $30.18 | $36.10 | -16.40% | 11.93x | 8.46x | 1.94x | 1.92x | 0.47x | $341.79M | 19.59% | $910.35M | 15.75 | $1.32B | 5.56 | ||
| EXEL | EXELIXIS INC | $49.71 | $31.77 | 56.48% | 15.93x | 15.84x | 5.41x | 6.45x | 1.16x | $917.69M | 7.15% | $1.94B | 7.49 | $12.44B | 11.78 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $220.48 | $83.32 | 164.63% | 27.91x | 23.90x | 15.97x | 4.43x | 1.89x | $122.22M | 2.79% | $997.32M | 50.16 | $4.76B | 21.08 | ||
| UTHR | UNITED THERAPEUTICS CORP | $569.88 | $268.60 | 112.17% | 19.46x | 19.33x | 7.82x | 4.10x | 1.80x | $1.02B | 4.10% | $5.90B | 135.66 | $22.91B | 13.37 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.15 | $14.72 | 111.68% | 17.21x | 15.09x | 6.38x | 3.76x | 2.21x | $208.13M | 5.46% | $1.01B | 8.28 | $3.06B | 9.13 | ||
| PBYI | PUMA BIOTECHNOLOGY INC | $7.14 | $4.42 | 61.38% | 14.28x | 17.50x | 1.60x | 2.83x | 1.45x | $53.60M | 14.76% | $128.42M | 2.53 | $341.09M | 7.58 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $712.77 | $442.78 | 60.98% | 16.75x | 15.13x | 4.97x | 2.38x | 1.17x | $4.11B | 5.55% | $31.42B | 302.15 | $74.47B | 12.96 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.40 | $6.92 | 180.39% | 32.33x | 6.09x | 0.93x | 1.36x | 1.84x | $109.24M | 5.36% | $1.51B | 14.34 | $2.62B | 31.67 | ||
| MDXG | MIMEDX GROUP INC | $3.56 | $1.82 | 95.92% | 16.95x | -261.76x | 1.36x | 2.18x | 1.82x | $69.36M | 13.12% | $242.94M | 1.64 | $388.07M | 7.12 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $435.17 | $179.17 | 142.89% | 25.58x | 22.35x | 9.05x | 5.70x | 1.74x | $3.71B | 3.36% | $19.36B | 76.20 | $106.94B | 19.83 | ||
| INCY | INCYTE CORP | $100.32 | $68.64 | 46.15% | 13.76x | 12.80x | 3.73x | 3.56x | 1.20x | $1.45B | 7.25% | $5.62B | 28.21 | $16.61B | 8.88 | ||
| VCYT | VERACYTE INC | $39.70 | $9.15 | 333.65% | 35.77x | 43.41x | 5.83x | 2.36x | 4.40x | $155.34M | 4.92% | $1.34B | 16.90 | $2.94B | 25.57 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.